Steven Axon - Chief Executive Officer @ Glycomine

Overview

CB Rank (Person)

Steven Axon is the Chief Executive Officer at Glycomine and was a CEO at Prothelia. He attended IMD and the University of Toronto.

Number of Current Jobs

Number of Past Jobs

is the

Chief Executive Officer

. Additionally,

has had

past job as the

Chief Executive Officer

Organization Name	Title At Company	Start Date	End Date
Prothelia	Chief Executive Officer	Sep 2019	Jun 2022

Hub Name	CB Rank (Hub)
Asahi Kasei Portfolio Companies	95,969
Pharmaceutical Companies with Late Stage Venture Funding	63,405
Sanderling Ventures Portfolio Companies	93,882
Biotechnology Late Stage Companies With Fewer Than 100 Employees	53,527
United States Therapeutics Female Founded Companies	47,404
Northeastern University Alumni Founded Companies	97,192
Sanofi Ventures Portfolio Companies	86,203
Biotechnology Companies with Late Stage Venture Funding	42,591
Biotechnology Late Stage Companies With Fewer Than 1000 Employees	42,820
Mission BioCapital Portfolio Companies	96,983